Osmia bicornis bicornis chromosome 4, iOsmBic2.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Apoidea; Megachilidae; Megachilinae; Osmia.
REFSEQ INFORMATION: The reference sequence is identical to\nOU015507.1.\nAssembly name: iOsmBic2.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/05/17. The original whole-genome shotgun project has the\naccession CAJRAL000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Osmia bicornis bicornis Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized LOC123987708, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123987708, transcript variant X1
uncharacterized LOC123987708, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123987707, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123987707, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC114882511, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC114882511, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC114882511, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123987712, transcript variant X2
uncharacterized LOC123987712, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
putative uncharacterized protein DDB_G0268364
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 60% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon GAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
piggyBac transposable element-derived protein 4-like
COORDINATES: polyA evidence [ECO:0006239]
CUGBP Elav-like family member 2, transcript variant X1
CUGBP Elav-like family member 2, transcript variant X3
CUGBP Elav-like family member 2, transcript variant X4
CUGBP Elav-like family member 2, transcript variant X5
CUGBP Elav-like family member 2, transcript variant X7
CUGBP Elav-like family member 2, transcript variant X8
CUGBP Elav-like family member 2, transcript variant X6
CUGBP Elav-like family member 2, transcript variant X2
CUGBP Elav-like family member 2 isoform X1
CUGBP Elav-like family member 2 isoform X3
CUGBP Elav-like family member 1 isoform X4
CUGBP Elav-like family member 2 isoform X2
CUGBP Elav-like family member 2, transcript variant X9
CUGBP Elav-like family member 2 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC114877909, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC114877909, transcript variant X2
uncharacterized LOC114877909, transcript variant X4
uncharacterized LOC114877909, transcript variant X3
uncharacterized LOC114877909, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC114877909, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC123987711
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
carboxypeptidase D-like, transcript variant X2
carboxypeptidase D-like, transcript variant X1
WD repeat-containing protein 55 homolog, transcript variant X2
WD repeat-containing protein 55 homolog, transcript variant X1
WD repeat-containing protein 55 homolog isoform X1
WD repeat-containing protein 55 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
serine/threonine-protein phosphatase PGAM5, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mitochondrial fission regulator 2-like, transcript variant X3
mitochondrial fission regulator 2-like, transcript variant X2
mitochondrial fission regulator 2-like, transcript variant X1
mitochondrial fission regulator 2-like isoform X3
mitochondrial fission regulator 2-like isoform X2
mitochondrial fission regulator 2-like isoform X1
ER degradation-enhancing alpha-mannosidase-like protein 3, transcript variant X2
ER degradation-enhancing alpha-mannosidase-like protein 3, transcript variant X1
ER degradation-enhancing alpha-mannosidase-like protein 3 isoform X2
ER degradation-enhancing alpha-mannosidase-like protein 3 isoform X1
multifunctional methyltransferase subunit TRM112-like protein
uncharacterized LOC114874710, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC114874710, transcript variant X1
uncharacterized protein LOC114874710 isoform X2
uncharacterized protein LOC114874710 isoform X1
HIG1 domain family member 1A, mitochondrial-like
dnaJ homolog subfamily C member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
dnaJ homolog subfamily C member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
dnaJ homolog subfamily C member 5 isoform X2
dnaJ homolog subfamily C member 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
BTB/POZ domain-containing protein 1-like, transcript variant X2
BTB/POZ domain-containing protein 1-like, transcript variant X1
BTB/POZ domain-containing protein 1-like isoform X1
BTB/POZ domain-containing protein 1-like isoform X2
ecdysone-induced protein 78C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ecdysone-induced protein 78C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ecdysone-induced protein 78C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ecdysone-induced protein 78C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable protein phosphatase 2C T23F11.1
ADP-ribosylation factor GTPase-activating protein 3, transcript variant X2
ADP-ribosylation factor GTPase-activating protein 3, transcript variant X1
ADP-ribosylation factor GTPase-activating protein 3 isoform X2
ADP-ribosylation factor GTPase-activating protein 3 isoform X1
STAGA complex 65 subunit gamma-like, transcript variant X2
STAGA complex 65 subunit gamma-like, transcript variant X1
STAGA complex 65 subunit gamma-like isoform X2
uncharacterized protein LOC114878996 isoform X1
MIT domain-containing protein 1-like, transcript variant X2
MIT domain-containing protein 1-like, transcript variant X1
NADH-cytochrome b5 reductase 3, transcript variant X1
NADH-cytochrome b5 reductase 3, transcript variant X2
NADH-cytochrome b5 reductase 2 isoform X1
NADH-cytochrome b5 reductase 3 isoform X2
uncharacterized LOC114879403, transcript variant X2
uncharacterized protein LOC114879403 isoform X2
uncharacterized LOC114879403, transcript variant X3
uncharacterized LOC114879403, transcript variant X4
uncharacterized LOC114879403, transcript variant X1
uncharacterized protein LOC114879403 isoform X1
uncharacterized protein LOC114879403 isoform X3
anaphase-promoting complex subunit 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
anaphase-promoting complex subunit 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
anaphase-promoting complex subunit 4 isoform X2
anaphase-promoting complex subunit 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
alpha,alpha-trehalose-phosphate synthase [UDP-forming], transcript variant X3
alpha,alpha-trehalose-phosphate synthase [UDP-forming], transcript variant X2
alpha,alpha-trehalose-phosphate synthase [UDP-forming], transcript variant X1
alpha,alpha-trehalose-phosphate synthase [UDP-forming], transcript variant X5
alpha,alpha-trehalose-phosphate synthase [UDP-forming], transcript variant X4
alpha,alpha-trehalose-phosphate synthase [UDP-forming] isoform X1
alpha,alpha-trehalose-phosphate synthase [UDP-forming] isoform X2
alpha,alpha-trehalose-phosphate synthase [UDP-forming] isoform X3
alpha,alpha-trehalose-phosphate synthase [UDP-forming] isoform X4
E3 ubiquitin-protein ligase TRAIP-like, transcript variant X1
E3 ubiquitin-protein ligase TRAIP-like, transcript variant X2
E3 ubiquitin-protein ligase TRAIP-like isoform X1
E3 ubiquitin-protein ligase TRAIP-like isoform X2
endoribonuclease CG2145-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
endoribonuclease CG2145-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
endoribonuclease CG2145-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
endoribonuclease CG2145-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uridylate-specific endoribonuclease B-like isoform X3
uridylate-specific endoribonuclease B-like isoform X2
uridylate-specific endoribonuclease B-like isoform X1
zinc finger MYND domain-containing protein 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
male-enhanced antigen 1, transcript variant X2
male-enhanced antigen 1, transcript variant X1
sodium- and chloride-dependent GABA transporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
sodium- and chloride-dependent GABA transporter 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
sodium- and chloride-dependent GABA transporter 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sodium- and chloride-dependent GABA transporter 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
sodium- and chloride-dependent GABA transporter 1-like
ribonucleoside-diphosphate reductase large subunit
DEK domain-containing chromatin-associated protein 4-like, transcript variant X4
DEK domain-containing chromatin-associated protein 4-like, transcript variant X1
DEK domain-containing chromatin-associated protein 4-like, transcript variant X2
DEK domain-containing chromatin-associated protein 4-like, transcript variant X3
DEK domain-containing chromatin-associated protein 4-like isoform X4
DEK domain-containing chromatin-associated protein 4-like isoform X1
DEK domain-containing chromatin-associated protein 4-like isoform X2
DEK domain-containing chromatin-associated protein 4-like isoform X3
GATA zinc finger domain-containing protein 24-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 84% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: uncharacterized protein LOC123987743
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X2
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X1
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X3
insulin-like growth factor-binding protein complex acid labile subunit
large proline-rich protein BAG6, transcript variant X1
large proline-rich protein BAG6, transcript variant X3
large proline-rich protein BAG6, transcript variant X8
large proline-rich protein BAG6, transcript variant X7
large proline-rich protein BAG6, transcript variant X5
large proline-rich protein BAG6, transcript variant X4
large proline-rich protein BAG6, transcript variant X6
large proline-rich protein BAG6, transcript variant X2
large proline-rich protein BAG6 isoform X6
large proline-rich protein BAG6 isoform X1
large proline-rich protein BAG6 isoform X5
large proline-rich protein BAG6 isoform X3
large proline-rich protein BAG6 isoform X2
large proline-rich protein BAG6 isoform X4
protein groucho-like, transcript variant X2
protein groucho-like, transcript variant X1
protein groucho-like, transcript variant X3
regulating synaptic membrane exocytosis protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
regulating synaptic membrane exocytosis protein 2, transcript variant X2
regulating synaptic membrane exocytosis protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
regulating synaptic membrane exocytosis protein 2, transcript variant X1
regulating synaptic membrane exocytosis protein 2 isoform X2
regulating synaptic membrane exocytosis protein 2 isoform X1
regulating synaptic membrane exocytosis protein 2, transcript variant X5
regulating synaptic membrane exocytosis protein 2, transcript variant X6
uncharacterized protein LOC114871388 isoform X3
cytochrome c oxidase assembly factor 3, mitochondrial, transcript variant X2
cytochrome c oxidase assembly factor 3, mitochondrial, transcript variant X1
cytochrome c oxidase assembly factor 3, mitochondrial
dimethyladenosine transferase 1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
zinc finger CCCH domain-containing protein 15 homolog, transcript variant X2
zinc finger CCCH domain-containing protein 15 homolog, transcript variant X1
zinc finger CCCH domain-containing protein 15 homolog isoform X2
zinc finger CCCH domain-containing protein 15 homolog isoform X1
eukaryotic translation initiation factor 3 subunit E
tudor domain-containing 6-like, transcript variant X4
tudor domain-containing 6-like, transcript variant X1
tudor domain-containing 6-like, transcript variant X3
tudor domain-containing 6-like, transcript variant X5
tudor domain-containing 6-like, transcript variant X2
tudor domain-containing 6-like isoform X4
tudor domain-containing 6-like isoform X2
tudor domain-containing 6-like isoform X1
tudor domain-containing 6-like isoform X3
E3 ubiquitin-protein ligase RNF146, transcript variant X1
E3 ubiquitin-protein ligase RNF146, transcript variant X2
E3 ubiquitin-protein ligase RNF146, transcript variant X3
E3 ubiquitin-protein ligase RNF146, transcript variant X4
E3 ubiquitin-protein ligase RNF146 isoform X4
E3 ubiquitin-protein ligase RNF146 isoform X3
E3 ubiquitin-protein ligase RNF146 isoform X2
E3 ubiquitin-protein ligase RNF146 isoform X1
cysteine--tRNA ligase, cytoplasmic, transcript variant X1
cysteine--tRNA ligase, cytoplasmic, transcript variant X3
cysteine--tRNA ligase, cytoplasmic, transcript variant X2
cysteine--tRNA ligase, cytoplasmic isoform X1
cysteine--tRNA ligase, cytoplasmic, transcript variant X4
cysteine--tRNA ligase, cytoplasmic isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
elongator complex protein 4, transcript variant X1
elongator complex protein 4, transcript variant X2
neurogenic protein mastermind, transcript variant X1
neurogenic protein mastermind, transcript variant X2
neurogenic protein mastermind isoform X1
neurogenic protein mastermind isoform X2
neurogenic protein mastermind, transcript variant X4
neurogenic protein mastermind, transcript variant X5
neurogenic protein mastermind isoform X4
neurogenic protein mastermind isoform X5
neurogenic protein mastermind, transcript variant X3
neurogenic protein mastermind isoform X3
heat shock protein 75 kDa, mitochondrial
fat-like cadherin-related tumor suppressor homolog, transcript variant X5
fat-like cadherin-related tumor suppressor homolog, transcript variant X4
fat-like cadherin-related tumor suppressor homolog, transcript variant X3
fat-like cadherin-related tumor suppressor homolog, transcript variant X7
fat-like cadherin-related tumor suppressor homolog, transcript variant X6
fat-like cadherin-related tumor suppressor homolog, transcript variant X2
fat-like cadherin-related tumor suppressor homolog, transcript variant X1
fat-like cadherin-related tumor suppressor homolog isoform X5
fat-like cadherin-related tumor suppressor homolog isoform X4
fat-like cadherin-related tumor suppressor homolog isoform X3
fat-like cadherin-related tumor suppressor homolog isoform X7
fat-like cadherin-related tumor suppressor homolog isoform X6
fat-like cadherin-related tumor suppressor homolog isoform X2
fat-like cadherin-related tumor suppressor homolog isoform X1
kunitz-type serine protease inhibitor Bt-KTI-like
CCR4-NOT transcription complex subunit 7, transcript variant X1
CCR4-NOT transcription complex subunit 7, transcript variant X2
CCR4-NOT transcription complex subunit 7 isoform X1
CCR4-NOT transcription complex subunit 7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
LARGE xylosyl- and glucuronyltransferase 1-like, transcript variant X2
LARGE xylosyl- and glucuronyltransferase 1-like, transcript variant X1
LARGE xylosyl- and glucuronyltransferase 1-like, transcript variant X3
LARGE xylosyl- and glucuronyltransferase 1-like, transcript variant X5
LARGE xylosyl- and glucuronyltransferase 1-like, transcript variant X4
LARGE xylosyl- and glucuronyltransferase 1-like isoform X1
LARGE xylosyl- and glucuronyltransferase 1-like isoform X3
LARGE xylosyl- and glucuronyltransferase 1-like isoform X2
leucine-rich repeat-containing protein 24, transcript variant X2
leucine-rich repeat-containing protein 24, transcript variant X5
leucine-rich repeat-containing protein 24, transcript variant X10
leucine-rich repeat-containing protein 24, transcript variant X3
leucine-rich repeat-containing protein 24, transcript variant X4
leucine-rich repeat-containing protein 24, transcript variant X9
leucine-rich repeat-containing protein 24, transcript variant X8
leucine-rich repeat-containing protein 24, transcript variant X7
leucine-rich repeat-containing protein 24, transcript variant X6
leucine-rich repeat-containing protein 24, transcript variant X11
leucine-rich repeat-containing protein 24, transcript variant X1
leucine-rich repeat-containing protein 24 isoform X1
uncharacterized protein LOC114872988 isoform X2
guanylate cyclase soluble subunit beta-1, transcript variant X5
guanylate cyclase soluble subunit beta-1, transcript variant X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 5 codons; deleted 9 bases in 7 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 5 codons; deleted 9 bases in 7 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: head-specific guanylate cyclase
guanylate cyclase soluble subunit beta-1, transcript variant X2
guanylate cyclase soluble subunit beta-1, transcript variant X1
guanylate cyclase soluble subunit beta-1 isoform X1
guanylate cyclase soluble subunit beta-1, transcript variant X3
guanylate cyclase soluble subunit beta-1 isoform X2
guanylate cyclase soluble subunit beta-1 isoform X3
uncharacterized LOC114872837, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC114872837, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC114872837 isoform X1
uncharacterized protein LOC114872837 isoform X2
uncharacterized LOC114877458, transcript variant X1
uncharacterized LOC114877458, transcript variant X3
uncharacterized LOC114877458, transcript variant X4
uncharacterized LOC114877458, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
neurobeachin-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
neurobeachin-like, transcript variant X3
neurobeachin-like, transcript variant X2
growth arrest-specific protein 2-like, transcript variant X1
growth arrest-specific protein 2-like, transcript variant X2
growth arrest-specific protein 2-like, transcript variant X4
growth arrest-specific protein 2-like, transcript variant X3
deoxycytidylate deaminase-like, transcript variant X2
deoxycytidylate deaminase-like, transcript variant X1
deoxycytidylate deaminase-like isoform X2
deoxycytidylate deaminase-like isoform X1
protein SHQ1 homolog, transcript variant X1
protein SHQ1 homolog, transcript variant X2
spliceosome-associated protein CWC15 homolog
laminin subunit alpha-1, transcript variant X2
laminin subunit alpha-1, transcript variant X1
laminin subunit alpha-1, transcript variant X3
uncharacterized LOC114880886, transcript variant X3
uncharacterized LOC114880886, transcript variant X2
uncharacterized LOC114880886, transcript variant X1
uncharacterized protein LOC114880886 isoform X2
uncharacterized protein LOC114880886 isoform X1
uncharacterized LOC114880887, transcript variant X5
uncharacterized LOC114880887, transcript variant X1
uncharacterized LOC114880887, transcript variant X3
uncharacterized LOC114880887, transcript variant X2
uncharacterized LOC114880887, transcript variant X4
ankyrin repeat domain-containing protein 12-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC114880883, transcript variant X2
uncharacterized LOC114880883, transcript variant X1
uncharacterized LOC114880883, transcript variant X3
uncharacterized LOC114880883, transcript variant X4
uncharacterized protein LOC114880883 isoform X1
uncharacterized protein LOC114880883 isoform X2
RISC-loading complex subunit TARBP2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
RISC-loading complex subunit TARBP2-like, transcript variant X2
RISC-loading complex subunit TARBP2-like isoform X1
RISC-loading complex subunit tarbp2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 70% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neurogenic locus notch homolog protein 1, transcript variant X1
uncharacterized protein LOC114879936 isoform X1
neurogenic locus notch homolog protein 1, transcript variant X3
neurogenic locus notch homolog protein 1 isoform X3
neurogenic locus notch homolog protein 1, transcript variant X2
neurogenic locus notch homolog protein 1 isoform X2
repressed by EFG1 protein 1-like, transcript variant X1
repressed by EFG1 protein 1-like, transcript variant X2
uncharacterized protein LOC114880039 isoform X1
uncharacterized protein LOC114880039 isoform X2
uncharacterized LOC114880060, transcript variant X3
repressed by EFG1 protein 1-like, transcript variant X3
uncharacterized protein LOC114880039 isoform X3
uncharacterized LOC114880060, transcript variant X4
uncharacterized LOC114880060, transcript variant X2
uncharacterized LOC114880060, transcript variant X1
repressed by EFG1 protein 1-like, transcript variant X5
repressed by EFG1 protein 1-like, transcript variant X4
repressed by EFG1 protein 1-like isoform X4
potassium channel subfamily T member 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
potassium channel subfamily T member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium channel subfamily T member 2, transcript variant X3
potassium channel subfamily T member 2, transcript variant X6
potassium channel subfamily T member 2, transcript variant X5
potassium channel subfamily T member 2, transcript variant X2
potassium channel subfamily T member 2, transcript variant X1
potassium channel subfamily T member 2, transcript variant X7
potassium channel subfamily T member 2, transcript variant X8
potassium channel subfamily T member 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium channel subfamily T member 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium channel subfamily T member 2 isoform X8
potassium channel subfamily T member 2 isoform X4
potassium channel subfamily T member 2 isoform X3
potassium channel subfamily T member 2 isoform X6
potassium channel subfamily T member 2 isoform X5
potassium channel subfamily T member 2 isoform X2
potassium channel subfamily T member 2 isoform X1
potassium channel subfamily T member 2 isoform X7
potassium channel subfamily T member 2 isoform X10
potassium channel subfamily T member 2 isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha, transcript variant X1
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha, transcript variant X2
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha isoform X1
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha isoform X2
histone-lysine N-methyltransferase SETMAR-like
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X9
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X10
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X5
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X6
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X3
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X5
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X4
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X7
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X3
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X1
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X2
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X8
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like, transcript variant X11
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X1
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X2
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X4
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1-like isoform X6
transfer RNA threonine (anticodon CGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized protein KIAA0513, transcript variant X2
uncharacterized protein KIAA0513, transcript variant X1
uncharacterized protein KIAA0513, transcript variant X3
uncharacterized protein KIAA0513 isoform X1
uncharacterized protein KIAA0513 isoform X3
uncharacterized protein KIAA0513 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
LON peptidase N-terminal domain and RING finger protein 3
uncharacterized LOC114879450, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC114879450, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC114879450 isoform X1
uncharacterized protein LOC114879450 isoform X2
uncharacterized LOC114879431, transcript variant X4
uncharacterized LOC114879431, transcript variant X3
uncharacterized LOC114879431, transcript variant X2
uncharacterized LOC114879431, transcript variant X1
etoposide-induced protein 2.4 homolog, transcript variant X2
etoposide-induced protein 2.4 homolog, transcript variant X3
etoposide-induced protein 2.4 homolog, transcript variant X1
etoposide-induced protein 2.4 homolog isoform X1
etoposide-induced protein 2.4 homolog isoform X2
transforming growth factor beta regulator 1
U4/U6 small nuclear ribonucleoprotein Prp3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nucleolysin TIAR, transcript variant X10
SEC23-interacting protein-like, transcript variant X2
SEC23-interacting protein-like, transcript variant X1
SEC23-interacting protein-like isoform X2
SEC23-interacting protein-like isoform X1
uncharacterized LOC114879862, transcript variant X1
uncharacterized protein LOC114879862 isoform X1
uncharacterized LOC114879862, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC114879862, transcript variant X2
uncharacterized protein LOC114879862 isoform X2
uncharacterized protein LOC114879862 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
octopamine receptor 1-like, transcript variant X3
octopamine receptor 1-like, transcript variant X1
octopamine receptor 1-like, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mesencephalic astrocyte-derived neurotrophic factor homolog, transcript variant X1
mesencephalic astrocyte-derived neurotrophic factor homolog, transcript variant X2
mesencephalic astrocyte-derived neurotrophic factor homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ubiquitin-protein ligase E3A, transcript variant X2
ubiquitin-protein ligase E3A, transcript variant X1
ubiquitin-protein ligase E3A, transcript variant X4
ubiquitin-protein ligase E3A, transcript variant X3
sodium- and chloride-dependent glycine transporter 1-like, transcript variant X1
sodium- and chloride-dependent glycine transporter 1-like, transcript variant X2
sodium- and chloride-dependent glycine transporter 1-like isoform X1
sodium- and chloride-dependent glycine transporter 1-like isoform X2
eye-specific diacylglycerol kinase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
eye-specific diacylglycerol kinase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
eye-specific diacylglycerol kinase, transcript variant X5
eye-specific diacylglycerol kinase, transcript variant X2
eye-specific diacylglycerol kinase, transcript variant X11
eye-specific diacylglycerol kinase, transcript variant X10
eye-specific diacylglycerol kinase, transcript variant X8
eye-specific diacylglycerol kinase, transcript variant X9
eye-specific diacylglycerol kinase, transcript variant X12
eye-specific diacylglycerol kinase, transcript variant X3
eye-specific diacylglycerol kinase, transcript variant X1
eye-specific diacylglycerol kinase isoform X3
eye-specific diacylglycerol kinase isoform X1
eye-specific diacylglycerol kinase, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
eye-specific diacylglycerol kinase isoform X2
troponin T, skeletal muscle, transcript variant X4
troponin T, skeletal muscle, transcript variant X2
troponin T, skeletal muscle, transcript variant X1
troponin T, skeletal muscle, transcript variant X5
troponin T, skeletal muscle, transcript variant X3
troponin T, skeletal muscle, transcript variant X6
U11/U12 small nuclear ribonucleoprotein 35 kDa protein-like, transcript variant X2
U11/U12 small nuclear ribonucleoprotein 35 kDa protein-like, transcript variant X1
U11/U12 small nuclear ribonucleoprotein 35 kDa protein-like isoform X2
U11/U12 small nuclear ribonucleoprotein 35 kDa protein-like isoform X1
calcium/calmodulin-dependent protein kinase I-like, transcript variant X1
calcium/calmodulin-dependent protein kinase I-like, transcript variant X2
calcium/calmodulin-dependent protein kinase I-like, transcript variant X3
calcium/calmodulin-dependent protein kinase I-like isoform X2
calcium/calmodulin-dependent protein kinase I-like isoform X1
calcium/calmodulin-dependent protein kinase I-like isoform X3
von Willebrand factor A domain-containing protein 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
von Willebrand factor A domain-containing protein 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
von Willebrand factor A domain-containing protein 8 isoform X1
von Willebrand factor A domain-containing protein 8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
transcription initiation factor TFIID subunit 1-like, transcript variant X1
transcription initiation factor TFIID subunit 1-like isoform X1
uncharacterized LOC114879495, transcript variant X1
uncharacterized LOC114879495, transcript variant X2
uncharacterized LOC114879495, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transcription initiation factor TFIID subunit 1-like, transcript variant X2
transcription initiation factor TFIID subunit 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC114879713, transcript variant X1
uncharacterized LOC114879713, transcript variant X4
uncharacterized LOC114879713, transcript variant X3
uncharacterized LOC114879713, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
modular serine protease-like, transcript variant X1
modular serine protease-like, transcript variant X2
probable serine/threonine-protein kinase kinX
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phospholipid-transporting ATPase ID, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
phospholipid-transporting ATPase ID, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
phospholipid-transporting ATPase ID, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phospholipid-transporting ATPase ID, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
phospholipid-transporting ATPase ID, transcript variant X4
phospholipid-transporting ATPase ID, transcript variant X1
phospholipid-transporting ATPase ID, transcript variant X3
phospholipid-transporting ATPase ID, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phospholipid-transporting ATPase ID, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phospholipid-transporting ATPase ID, transcript variant X10
phospholipid-transporting ATPase ID, transcript variant X12
phospholipid-transporting ATPase ID, transcript variant X11
phospholipid-transporting ATPase ID isoform X5
phospholipid-transporting ATPase ID isoform X4
phospholipid-transporting ATPase ID isoform X3
phospholipid-transporting ATPase ID isoform X2
phospholipid-transporting ATPase ID isoform X1
phospholipid-transporting ATPase ID isoform X9
phospholipid-transporting ATPase ID isoform X8
phospholipid-transporting ATPase ID isoform X6
phospholipid-transporting ATPase ID isoform X7
uncharacterized LOC114880914, transcript variant X2
uncharacterized LOC114880914, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
UPF0669 protein C6orf120 homolog, transcript variant X2
UPF0669 protein C6orf120 homolog, transcript variant X1
probable serine/threonine-protein kinase dyrk2, transcript variant X1
probable serine/threonine-protein kinase dyrk2, transcript variant X2
probable serine/threonine-protein kinase dyrk2 isoform X1
probable serine/threonine-protein kinase DDB_G0278845 isoform X2
uncharacterized LOC114881309, transcript variant X1
uncharacterized LOC114881309, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
coiled-coil domain-containing protein 43
neither inactivation nor afterpotential protein G, transcript variant X1
neither inactivation nor afterpotential protein G, transcript variant X2
neither inactivation nor afterpotential protein G isoform X1
neither inactivation nor afterpotential protein G isoform X2
zinc finger protein chinmo, transcript variant X3
zinc finger protein chinmo, transcript variant X4
zinc finger protein chinmo, transcript variant X5
zinc finger protein chinmo, transcript variant X1
zinc finger protein chinmo, transcript variant X6
zinc finger protein chinmo, transcript variant X2
cytochrome b-c1 complex subunit Rieske, mitochondrial, transcript variant X2
cytochrome b-c1 complex subunit Rieske, mitochondrial, transcript variant X1
cytochrome b-c1 complex subunit Rieske, mitochondrial isoform X1
cytochrome b-c1 complex subunit Rieske, mitochondrial isoform X2
probable ribosome biogenesis protein RLP24
uncharacterized LOC114880641, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC114880641, transcript variant X2
uncharacterized LOC114880641, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC114880641 isoform X1
uncharacterized LOC114880641, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC114880641 isoform X2
lysophospholipid acyltransferase 6, transcript variant X2
lysophospholipid acyltransferase 6, transcript variant X1
mitochondrial import inner membrane translocase subunit Tim8-like
ufm1-specific protease 2, transcript variant X1
ufm1-specific protease 2, transcript variant X2
tyrosine-protein kinase CSK, transcript variant X2
tyrosine-protein kinase CSK, transcript variant X1
uncharacterized LOC114881093, transcript variant X2
uncharacterized LOC114881093, transcript variant X1
uncharacterized protein LOC114881093 isoform X2
uncharacterized protein LOC114881093 isoform X1
cation channel sperm-associated protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zwei Ig domain protein zig-8-like, transcript variant X3
zwei Ig domain protein zig-8-like, transcript variant X4
zwei Ig domain protein zig-8-like, transcript variant X1
zwei Ig domain protein zig-8-like, transcript variant X2
zwei Ig domain protein zig-8-like isoform X1
zwei Ig domain protein zig-8-like isoform X2
zwei Ig domain protein zig-8-like isoform X3
zwei Ig domain protein zig-8-like isoform X4
zwei Ig domain protein zig-8-like, transcript variant X6
zwei Ig domain protein zig-8-like, transcript variant X5
zwei Ig domain protein zig-8-like isoform X5
zwei Ig domain protein zig-8-like isoform X6
protein unc-13 homolog B, transcript variant X14
protein unc-13 homolog B, transcript variant X8
protein unc-13 homolog B, transcript variant X11
protein unc-13 homolog B, transcript variant X13
protein unc-13 homolog B, transcript variant X10
protein unc-13 homolog B, transcript variant X9
protein unc-13 homolog B, transcript variant X12
protein unc-13 homolog B, transcript variant X7
protein unc-13 homolog B, transcript variant X15
protein unc-13 homolog B, transcript variant X2
protein unc-13 homolog B, transcript variant X4
protein unc-13 homolog B, transcript variant X5
protein unc-13 homolog B, transcript variant X3
protein unc-13 homolog B, transcript variant X1
protein unc-13 homolog B, transcript variant X6
uncharacterized protein LOC114873991 isoform X4
uncharacterized protein LOC114873991 isoform X5
uncharacterized protein LOC114873991 isoform X3
uncharacterized protein LOC114873991 isoform X6
uncharacterized protein LOC114873991 isoform X2
uncharacterized protein LOC114873991 isoform X1
unconventional myosin-IXAa-like, transcript variant X2
unconventional myosin-IXAa-like, transcript variant X1
unconventional myosin-IXAa-like, transcript variant X4
unconventional myosin-IXAa-like, transcript variant X5
unconventional myosin-IXAa-like, transcript variant X3
unconventional myosin-IXAa-like, transcript variant X6
unconventional myosin-IXAa-like, transcript variant X7
unconventional myosin-IXAa-like, transcript variant X8
RNA-binding protein MEX3B, transcript variant X2
RNA-binding protein MEX3B, transcript variant X1
methyl-CpG-binding domain protein 2, transcript variant X2
methyl-CpG-binding domain protein 2, transcript variant X1
methyl-CpG-binding domain protein 2, transcript variant X3
methyl-CpG-binding domain protein 2 isoform X3
methyl-CpG-binding domain protein 3 isoform X2
methyl-CpG-binding domain protein 3 isoform X1
ribosome-recycling factor, mitochondrial
epidermal growth factor receptor, transcript variant X3
epidermal growth factor receptor, transcript variant X2
epidermal growth factor receptor, transcript variant X1
epidermal growth factor receptor isoform X2
epidermal growth factor receptor isoform X1
FK506-binding protein 2, transcript variant X1
FK506-binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
FH1/FH2 domain-containing protein 3, transcript variant X1
FH1/FH2 domain-containing protein 3, transcript variant X2
FH1/FH2 domain-containing protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
FH1/FH2 domain-containing protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
FH1/FH2 domain-containing protein 3 isoform X1
FH1/FH2 domain-containing protein 3 isoform X2
FH1/FH2 domain-containing protein 3 isoform X3
FH1/FH2 domain-containing protein 3 isoform X4
paramyosin, short form-like, transcript variant X2
paramyosin, short form-like, transcript variant X3
paramyosin, short form-like, transcript variant X1
TGF-beta receptor type-1, transcript variant X3
TGF-beta receptor type-1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
TGF-beta receptor type-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
TGF-beta receptor type-1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
TGF-beta receptor type-1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TGF-beta receptor type-1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
TGF-beta receptor type-1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
UDP-glucose 6-dehydrogenase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
UDP-glucose 6-dehydrogenase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
UDP-glucose 6-dehydrogenase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
vacuolar protein sorting-associated protein 53 homolog, transcript variant X1
vacuolar protein sorting-associated protein 53 homolog, transcript variant X2
vacuolar protein sorting-associated protein 53 homolog isoform X2
vacuolar protein sorting-associated protein 53 homolog isoform X1
N-alpha-acetyltransferase 15, NatA auxiliary subunit
uncharacterized LOC114873274, transcript variant X1
uncharacterized LOC114873274, transcript variant X2
DNA-directed RNA polymerase III subunit RPC3, transcript variant X2
DNA-directed RNA polymerase III subunit RPC3, transcript variant X1
DNA-directed RNA polymerase III subunit RPC3
transcription factor SOX-5-like, transcript variant X3
transcription factor SOX-5-like, transcript variant X2
transcription factor SOX-5-like, transcript variant X1
transcription factor SOX-5-like, transcript variant X4
transcription factor SOX-5-like isoform X2
transcription factor SOX-5-like isoform X1
transcription factor SOX-5-like isoform X3
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
dosage compensation regulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
dosage compensation regulator, transcript variant X2
dosage compensation regulator isoform X1
dosage compensation regulator isoform X2
ubiquitin-like protein 3, transcript variant X2
ubiquitin-like protein 3, transcript variant X1
torso-like protein, transcript variant X4
torso-like protein, transcript variant X3
torso-like protein, transcript variant X2
torso-like protein, transcript variant X1
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X2
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X5
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X3
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X4
ankyrin repeat and SAM domain-containing protein 1A-like, transcript variant X1
ankyrin repeat and SAM domain-containing protein 1A-like isoform X4
uncharacterized protein LOC114874768 isoform X2
ankyrin repeat and SAM domain-containing protein 1A-like isoform X3
uncharacterized protein LOC114874768 isoform X1
transmembrane 7 superfamily member 3-like, transcript variant X1
transmembrane 7 superfamily member 3-like, transcript variant X2
transmembrane 7 superfamily member 3-like isoform X2
transmembrane 7 superfamily member 3-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC1-like, transcript variant X2
protein O-mannosyl-transferase TMTC1-like, transcript variant X1
protein O-mannosyl-transferase TMTC1-like isoform X2
protein O-mannosyl-transferase TMTC1-like isoform X1
UDP-glycosyltransferase UGT5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 115 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
UDP-glycosyltransferase UGT5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UDP-glycosyltransferase UGT5-like isoform X1
UDP-glycosyltransferase UGT5-like isoform X2
beta-1,4-glucuronyltransferase 1, transcript variant X1
beta-1,4-glucuronyltransferase 1, transcript variant X2
beta-1,4-glucuronyltransferase 1 isoform X1
beta-1,4-glucuronyltransferase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 51% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC114874749, transcript variant X2
uncharacterized LOC114874749, transcript variant X3
uncharacterized LOC114874749, transcript variant X1
fork head domain transcription factor slp1-like
protein PF14_0175-like, transcript variant X6
protein PF14_0175-like, transcript variant X4
protein PF14_0175-like, transcript variant X2
protein PF14_0175-like, transcript variant X1
protein PF14_0175-like, transcript variant X3
protein PF14_0175-like, transcript variant X5
structural maintenance of chromosomes protein 1A
palmitoyl-protein thioesterase 1, transcript variant X4
palmitoyl-protein thioesterase 1, transcript variant X3
palmitoyl-protein thioesterase 1, transcript variant X1
palmitoyl-protein thioesterase 1, transcript variant X5
palmitoyl-protein thioesterase 1, transcript variant X7
jerky protein homolog-like, transcript variant X1
jerky protein homolog-like, transcript variant X2
palmitoyl-protein thioesterase 1 isoform X1
palmitoyl-protein thioesterase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
palmitoyl-protein thioesterase 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
palmitoyl-protein thioesterase 1 isoform X2
DENN domain-containing protein Crag, transcript variant X2
DENN domain-containing protein Crag, transcript variant X3
DENN domain-containing protein Crag, transcript variant X1
DENN domain-containing protein Crag, transcript variant X4
DENN domain-containing protein Crag isoform X1
DENN domain-containing protein Crag isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC114874737
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC123987716, transcript variant X1
uncharacterized LOC123987716, transcript variant X2
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
kynurenine formamidase, transcript variant X1
kynurenine formamidase, transcript variant X2
kynurenine formamidase, transcript variant X3
uncharacterized protein MAL13P1.304-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein MAL13P1.304-like, transcript variant X3
uncharacterized protein MAL13P1.304-like, transcript variant X1
uncharacterized protein MAL13P1.304-like, transcript variant X2
uncharacterized protein MAL13P1.304-like
mediator of RNA polymerase II transcription subunit 12
uncharacterized LOC114874721, transcript variant X2
uncharacterized LOC114874721, transcript variant X1
uncharacterized protein LOC114874721 isoform X1
uncharacterized protein LOC114874721 isoform X2
eukaryotic translation initiation factor 3 subunit M
ethanolamine kinase 1, transcript variant X11
ethanolamine kinase 1, transcript variant X8
ethanolamine kinase 1, transcript variant X2
ethanolamine kinase 1, transcript variant X7
ethanolamine kinase 1, transcript variant X9
ethanolamine kinase 1, transcript variant X4
ethanolamine kinase 1, transcript variant X5
ethanolamine kinase 1, transcript variant X6
ethanolamine kinase 1, transcript variant X10
ethanolamine kinase 1, transcript variant X1
ethanolamine kinase 1, transcript variant X3
ethanolamine kinase 1, transcript variant X12
Bloom syndrome protein homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Bloom syndrome protein homolog, transcript variant X2
Bloom syndrome protein homolog isoform X1
Bloom syndrome protein homolog isoform X2
succinate dehydrogenase assembly factor 2, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
eIF-2-alpha kinase GCN2, transcript variant X3
eIF-2-alpha kinase GCN2, transcript variant X1
eIF-2-alpha kinase GCN2, transcript variant X2
28S ribosomal protein S30, mitochondrial
tubulin glycylase 3A-like, transcript variant X2
tubulin glycylase 3A-like, transcript variant X1
tubulin glycylase 3A-like, transcript variant X3
lysosomal acid glucosylceramidase-like, transcript variant X3
lysosomal acid glucosylceramidase-like, transcript variant X1
lysosomal acid glucosylceramidase-like, transcript variant X2
tubulin glycylase 3A-like, transcript variant X5
tubulin glycylase 3A-like, transcript variant X4
putative fatty acyl-CoA reductase CG5065
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 63% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metalloproteinase with thrombospondin motifs 7-like, transcript variant X3
A disintegrin and metalloproteinase with thrombospondin motifs 7-like, transcript variant X4
A disintegrin and metalloproteinase with thrombospondin motifs 7-like, transcript variant X1
A disintegrin and metalloproteinase with thrombospondin motifs 7-like, transcript variant X6
A disintegrin and metalloproteinase with thrombospondin motifs 7-like, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 7-like, transcript variant X5
A disintegrin and metalloproteinase with thrombospondin motifs 7-like isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 7-like isoform X2
branched-chain-amino-acid aminotransferase, cytosolic
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial-like
uncharacterized LOC114877236, transcript variant X5
uncharacterized LOC114877236, transcript variant X6
uncharacterized LOC114877236, transcript variant X1
uncharacterized LOC114877236, transcript variant X7
uncharacterized LOC114877236, transcript variant X3
uncharacterized LOC114877236, transcript variant X4
uncharacterized protein LOC114877236 isoform X4
uncharacterized protein LOC114877236 isoform X5
uncharacterized protein LOC114877236 isoform X1
uncharacterized protein LOC114877236 isoform X2
uncharacterized protein LOC114877236 isoform X3
uncharacterized protein LOC114877236 isoform X6
uncharacterized LOC114877236, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
heat shock protein beta-1, transcript variant X1
heat shock protein beta-1, transcript variant X2
heat shock protein beta-1, transcript variant X3
thyroid transcription factor 1-associated protein 26 homolog
AP-2 complex subunit alpha, transcript variant X1
AP-2 complex subunit alpha, transcript variant X2
tumor necrosis factor receptor superfamily member 4-like
presenilins-associated rhomboid-like protein, mitochondrial, transcript variant X4
presenilins-associated rhomboid-like protein, mitochondrial, transcript variant X5
presenilins-associated rhomboid-like protein, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
presenilins-associated rhomboid-like protein, mitochondrial, transcript variant X3
presenilins-associated rhomboid-like protein, mitochondrial, transcript variant X1
presenilins-associated rhomboid-like protein, mitochondrial isoform X1
presenilins-associated rhomboid-like protein, mitochondrial, transcript variant X6
presenilins-associated rhomboid-like protein, mitochondrial isoform X2
coiled-coil domain-containing protein 39
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1-like
glutamine synthetase 2 cytoplasmic, transcript variant X2
glutamine synthetase 2 cytoplasmic, transcript variant X1
glutamine synthetase 2 cytoplasmic isoform X1
glutamine synthetase 2 cytoplasmic isoform X2
serine/threonine-protein phosphatase 5-like
integrator complex subunit 3, transcript variant X2
integrator complex subunit 3, transcript variant X3
integrator complex subunit 3, transcript variant X1
protein fem-1 homolog CG6966, transcript variant X1
protein fem-1 homolog CG6966, transcript variant X3
protein fem-1 homolog CG6966, transcript variant X2
myelin expression factor 2, transcript variant X3
myelin expression factor 2, transcript variant X1
myelin expression factor 2, transcript variant X2
heterogeneous nuclear ribonucleoprotein M isoform X2
heterogeneous nuclear ribonucleoprotein M isoform X3
probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial
uncharacterized LOC123987738, transcript variant X2
uncharacterized LOC123987738, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
phosphatidylinositol 3-kinase catalytic subunit type 3
JNK-interacting protein 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
JNK-interacting protein 3, transcript variant X9
JNK-interacting protein 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
JNK-interacting protein 3, transcript variant X11
JNK-interacting protein 3, transcript variant X1
JNK-interacting protein 3, transcript variant X6
JNK-interacting protein 3, transcript variant X3
JNK-interacting protein 3, transcript variant X4
JNK-interacting protein 3, transcript variant X2
JNK-interacting protein 3, transcript variant X5
JNK-interacting protein 3, transcript variant X13
JNK-interacting protein 3, transcript variant X7
JNK-interacting protein 3, transcript variant X12
uncharacterized LOC114876599, transcript variant X2
uncharacterized LOC114876599, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X6
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X6
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X3
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
death-associated protein kinase 1-like, transcript variant X1
death-associated protein kinase 1-like, transcript variant X3
death-associated protein kinase 1-like, transcript variant X4
death-associated protein kinase 1-like, transcript variant X2
death-associated protein kinase 1-like, transcript variant X5
death-associated protein kinase 1-like, transcript variant X6
death-associated protein kinase 1-like isoform X3
death-associated protein kinase 1-like isoform X4
death-associated protein kinase 1-like isoform X1
death-associated protein kinase 1-like isoform X2
death-associated protein kinase 1-like isoform X5
60S ribosomal protein L14, transcript variant X1
60S ribosomal protein L14, transcript variant X2
KIF-binding protein, transcript variant X1
KIF-binding protein, transcript variant X2
RAB6A-GEF complex partner protein 2, transcript variant X1
RAB6A-GEF complex partner protein 2, transcript variant X2
RAB6A-GEF complex partner protein 2, transcript variant X3
RAB6A-GEF complex partner protein 2 isoform X1
RAB6A-GEF complex partner protein 2 isoform X2
RAB6A-GEF complex partner protein 2 isoform X3
ribosome biogenesis protein BOP1 homolog
NGFI-A-binding protein homolog, transcript variant X1
NGFI-A-binding protein homolog, transcript variant X2
NGFI-A-binding protein homolog isoform X1
NGFI-A-binding protein homolog isoform X2
N-acetylgalactosaminyltransferase 7, transcript variant X3
N-acetylgalactosaminyltransferase 7, transcript variant X1
N-acetylgalactosaminyltransferase 7, transcript variant X2
N-acetylgalactosaminyltransferase 7 isoform X1
N-acetylgalactosaminyltransferase 7 isoform X2
adipokinetic hormone/corazonin-related peptide receptor variant I
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
dmX-like protein 2, transcript variant X2
dmX-like protein 2, transcript variant X1
dmX-like protein 2, transcript variant X3
dmX-like protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC114876195, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC114876195, transcript variant X4
uncharacterized LOC114876195, transcript variant X1
uncharacterized LOC114876195, transcript variant X5
uncharacterized LOC114876195, transcript variant X3
uncharacterized protein LOC114876195 isoform X1
uncharacterized protein LOC114876195 isoform X2
uncharacterized protein LOC114876195 isoform X3
SURP and G-patch domain-containing protein 1, transcript variant X1
SURP and G-patch domain-containing protein 1, transcript variant X2
SURP and G-patch domain-containing protein 1, transcript variant X3
SURP and G-patch domain-containing protein 1 isoform X1
SURP and G-patch domain-containing protein 1 isoform X2
SURP and G-patch domain-containing protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC114875786 isoform X2
Meckel syndrome type 1 protein-like, transcript variant X2
Meckel syndrome type 1 protein-like, transcript variant X1
Meckel syndrome type 1 protein-like isoform X2
Meckel syndrome type 1 protein-like isoform X1
rhomboid-related protein 3, transcript variant X1
rhomboid-related protein 3, transcript variant X5
rhomboid-related protein 3, transcript variant X3
rhomboid-related protein 3, transcript variant X2
rhomboid-related protein 3, transcript variant X4
39S ribosomal protein L44, mitochondrial
protein split ends-like, transcript variant X2
protein split ends-like, transcript variant X5
protein split ends-like, transcript variant X6
protein split ends-like, transcript variant X4
protein split ends-like, transcript variant X1
protein split ends-like, transcript variant X3
uncharacterized protein LOC114876882 isoform X1
protein split ends-like, transcript variant X7
uncharacterized protein LOC114876882 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
vacuolar protein sorting-associated protein 37B, transcript variant X1
vacuolar protein sorting-associated protein 37B, transcript variant X2
vacuolar protein sorting-associated protein 37B
chaperone protein DnaJ-like, transcript variant X3
chaperone protein DnaJ-like, transcript variant X1
chaperone protein DnaJ-like, transcript variant X2
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial, transcript variant X4
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial, transcript variant X2
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial, transcript variant X3
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial, transcript variant X7
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial, transcript variant X6
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial, transcript variant X5
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial, transcript variant X1
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial isoform X4
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial isoform X3
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial isoform X2
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial isoform X1
serum response factor-binding protein 1-like
elongation factor-like GTPase 1, transcript variant X2
elongation factor-like GTPase 1, transcript variant X1
elongation factor-like GTPase 1, transcript variant X3
very-long-chain 3-oxoacyl-CoA reductase-like, transcript variant X1
very-long-chain 3-oxoacyl-CoA reductase-like, transcript variant X2
very-long-chain 3-oxoacyl-CoA reductase-like isoform X1
very-long-chain 3-oxoacyl-CoA reductase-like isoform X2
TRAF3-interacting protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
TRAF3-interacting protein 1-like, transcript variant X1
TRAF3-interacting protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC114876033 isoform X3
TRAF3-interacting protein 1-like isoform X1
TRAF3-interacting protein 1-like isoform X2
E3 ubiquitin-protein ligase Iruka-like, transcript variant X1
E3 ubiquitin-protein ligase Iruka-like, transcript variant X2
E3 ubiquitin-protein ligase Iruka-like isoform X1
E3 ubiquitin-protein ligase Iruka-like isoform X2
uncharacterized LOC114876019, transcript variant X2
uncharacterized LOC114876019, transcript variant X3
uncharacterized LOC114876019, transcript variant X1
steroid receptor seven-up, isoforms B/C, transcript variant X2
steroid receptor seven-up, isoforms B/C, transcript variant X1
nuclear receptor subfamily 2 group F member 1-A isoform X1
nuclear receptor subfamily 2 group F member 1-A isoform X2
steroid receptor seven-up, isoforms B/C, transcript variant X3
steroid receptor seven-up, isoforms B/C isoform X3
serine/threonine-protein kinase tricornered, transcript variant X2
serine/threonine-protein kinase tricornered, transcript variant X4
serine/threonine-protein kinase tricornered, transcript variant X1
serine/threonine-protein kinase tricornered, transcript variant X3
serine/threonine-protein kinase tricornered, transcript variant X9
serine/threonine-protein kinase tricornered, transcript variant X6
serine/threonine-protein kinase tricornered, transcript variant X7
serine/threonine-protein kinase tricornered, transcript variant X5
serine/threonine-protein kinase tricornered, transcript variant X8
serine/threonine-protein kinase tricornered isoform X2
serine/threonine-protein kinase tricornered isoform X4
serine/threonine-protein kinase tricornered isoform X1
serine/threonine-protein kinase tricornered isoform X3
serine/threonine-protein kinase tricornered isoform X5
serine/threonine-protein kinase tricornered isoform X6
transcription initiation factor TFIID subunit 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
biogenesis of lysosome-related organelles complex 1 subunit 4
LOW QUALITY PROTEIN: putative fatty acyl-CoA reductase CG5065
guanine nucleotide-binding protein-like 1
la-related protein 1B, transcript variant X1
la-related protein 1B, transcript variant X2
la-related protein 1B, transcript variant X3
la-related protein 1B, transcript variant X4
la-related protein 1B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
heart- and neural crest derivatives-expressed protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
nose resistant to fluoxetine protein 6-like
4-hydroxybenzoate polyprenyltransferase, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC114875294, transcript variant X1
uncharacterized LOC114875294, transcript variant X2
THO complex subunit 3, transcript variant X2
THO complex subunit 3, transcript variant X1
cilia- and flagella-associated protein 97-like
LOW QUALITY PROTEIN: transmembrane protein 131
RNA-binding protein 28, transcript variant X2
RNA-binding protein 28, transcript variant X1
probable cytochrome P450 301a1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 53 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC114874576, transcript variant X1
uncharacterized LOC114874576, transcript variant X2
uncharacterized protein LOC114874576 isoform X1
uncharacterized protein LOC114874576 isoform X2
Hermansky-Pudlak syndrome 5 protein homolog
cleavage and polyadenylation specificity factor subunit 6, transcript variant X6
cleavage and polyadenylation specificity factor subunit 6 isoform X6
cleavage and polyadenylation specificity factor subunit 6, transcript variant X2
cleavage and polyadenylation specificity factor subunit 6, transcript variant X5
cleavage and polyadenylation specificity factor subunit 6, transcript variant X1
cleavage and polyadenylation specificity factor subunit 6, transcript variant X3
cleavage and polyadenylation specificity factor subunit 6 isoform X2
cleavage and polyadenylation specificity factor subunit 6 isoform X5
cleavage and polyadenylation specificity factor subunit 6 isoform X1
cleavage and polyadenylation specificity factor subunit 6 isoform X3
cleavage and polyadenylation specificity factor subunit 6, transcript variant X4
cleavage and polyadenylation specificity factor subunit 6 isoform X4
nucleosome assembly protein 1-like 1, transcript variant X1
nucleosome assembly protein 1-like 1, transcript variant X3
nucleosome assembly protein 1-like 1, transcript variant X2
nucleosome assembly protein 1-like 1 isoform X1
nucleosome assembly protein 1-like 1 isoform X2
serine-rich adhesin for platelets-like, transcript variant X3
serine-rich adhesin for platelets-like, transcript variant X4
serine-rich adhesin for platelets-like, transcript variant X5
serine-rich adhesin for platelets-like, transcript variant X2
serine-rich adhesin for platelets-like, transcript variant X1
serine-rich adhesin for platelets-like isoform X4
serine-rich adhesin for platelets-like isoform X2
serine-rich adhesin for platelets-like isoform X1
serine-rich adhesin for platelets-like isoform X3
asparagine synthetase [glutamine-hydrolyzing], transcript variant X1
asparagine synthetase [glutamine-hydrolyzing] isoform X1
asparagine synthetase [glutamine-hydrolyzing], transcript variant X2
asparagine synthetase [glutamine-hydrolyzing] isoform X2
transcriptional adapter 1-like, transcript variant X3
transcriptional adapter 1-like, transcript variant X4
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transcriptional adapter 1-like, transcript variant X1
transcriptional adapter 1-like, transcript variant X2
transcriptional adapter 1-like isoform X1
transcriptional adapter 1-like isoform X2
transcriptional adapter 1-like isoform X3
transcriptional adapter 1-like isoform X4
AP-3 complex subunit mu-1, transcript variant X1
AP-3 complex subunit mu-1, transcript variant X2
conserved oligomeric Golgi complex subunit 5, transcript variant X1
conserved oligomeric Golgi complex subunit 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
conserved oligomeric Golgi complex subunit 5
ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1-like
dedicator of cytokinesis protein 9, transcript variant X2
dedicator of cytokinesis protein 9, transcript variant X7
dedicator of cytokinesis protein 9, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dedicator of cytokinesis protein 9, transcript variant X6
dedicator of cytokinesis protein 9, transcript variant X4
dedicator of cytokinesis protein 9, transcript variant X3
dedicator of cytokinesis protein 9, transcript variant X1
dedicator of cytokinesis protein 9, transcript variant X8
dedicator of cytokinesis protein 9 isoform X7
dedicator of cytokinesis protein 9 isoform X6
dedicator of cytokinesis protein 9 isoform X4
dedicator of cytokinesis protein 9 isoform X5
dedicator of cytokinesis protein 9 isoform X3
dedicator of cytokinesis protein 9 isoform X2
dedicator of cytokinesis protein 9 isoform X1
protein phosphatase 1L, transcript variant X2
protein phosphatase 1L, transcript variant X1
protein phosphatase 1L, transcript variant X3
protein phosphatase 1L, transcript variant X4
cysteine protease ATG4B, transcript variant X2
cysteine protease ATG4B, transcript variant X3
cysteine protease ATG4B, transcript variant X1
cysteine protease ATG4B, transcript variant X4
vesicular glutamate transporter 2, transcript variant X2
vesicular glutamate transporter 2, transcript variant X1
vesicular glutamate transporter 2 isoform X1
vesicular glutamate transporter 2 isoform X2
meiosis-specific coiled-coil domain-containing protein MEIOC-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
cytochrome c oxidase assembly protein COX16 homolog, mitochondrial
U6 snRNA-associated Sm-like protein LSm1, transcript variant X2
U6 snRNA-associated Sm-like protein LSm1, transcript variant X1
U6 snRNA-associated Sm-like protein LSm1 isoform X1
U6 snRNA-associated Sm-like protein LSm1, transcript variant X3
U6 snRNA-associated Sm-like protein LSm1 isoform X2
uncharacterized LOC114874850, transcript variant X2
uncharacterized LOC114874850, transcript variant X1
uncharacterized protein LOC114874850 isoform X2
uncharacterized protein LOC114874850 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 11 bases in 11 codons; deleted 9 bases in 6 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 11 bases in 11 codons; deleted 9 bases in 6 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC114874836
mitotic checkpoint protein BUB3, transcript variant X4
mitotic checkpoint protein BUB3, transcript variant X5
mitotic checkpoint protein BUB3, transcript variant X2
mitotic checkpoint protein BUB3, transcript variant X3
mitotic checkpoint protein BUB3, transcript variant X1
mitotic checkpoint protein BUB3, transcript variant X6
mitochondrial coenzyme A transporter SLC25A42, transcript variant X1
mitochondrial coenzyme A transporter SLC25A42, transcript variant X2
mitochondrial coenzyme A transporter SLC25A42
TBC1 domain family member 9, transcript variant X1
TBC1 domain family member 9, transcript variant X2
ankyrin repeat domain-containing protein 29, transcript variant X1
ankyrin repeat domain-containing protein 29, transcript variant X2
ankyrin repeat domain-containing protein 29 isoform X1
ankyrin repeat domain-containing protein 29 isoform X2
lymphokine-activated killer T-cell-originated protein kinase, transcript variant X2
lymphokine-activated killer T-cell-originated protein kinase isoform X2
lymphokine-activated killer T-cell-originated protein kinase, transcript variant X1
lymphokine-activated killer T-cell-originated protein kinase isoform X1
serine/threonine-protein phosphatase PGAM5, mitochondrial-like
nuclear speckle splicing regulatory protein 1
DNA-directed RNA polymerase I subunit RPA1
neutral and basic amino acid transport protein rBAT-like, transcript variant X1
neutral and basic amino acid transport protein rBAT-like, transcript variant X3
neutral and basic amino acid transport protein rBAT-like, transcript variant X4
neutral and basic amino acid transport protein rBAT-like, transcript variant X5
neutral and basic amino acid transport protein rBAT-like, transcript variant X2
neutral and basic amino acid transport protein rBAT-like isoform X1
neutral and basic amino acid transport protein rBAT-like isoform X2
neutral and basic amino acid transport protein rBAT-like isoform X3
neutral and basic amino acid transport protein rBAT-like isoform X4
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X1
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X2
probable multidrug resistance-associated protein lethal(2)03659 isoform X1
probable multidrug resistance-associated protein lethal(2)03659 isoform X2
putative sodium-dependent multivitamin transporter
WD repeat-containing protein 26, transcript variant X3
WD repeat-containing protein 26, transcript variant X1
WD repeat-containing protein 26, transcript variant X2
WD repeat-containing protein 26 isoform X1
WD repeat-containing protein 26 isoform X2
ATP synthase subunit g, mitochondrial-like
coiled-coil and C2 domain-containing protein 1-like, transcript variant X1
coiled-coil and C2 domain-containing protein 1-like, transcript variant X3
coiled-coil and C2 domain-containing protein 1-like, transcript variant X2
coiled-coil and C2 domain-containing protein 1-like, transcript variant X4
coiled-coil and C2 domain-containing protein 1-like isoform X1
coiled-coil and C2 domain-containing protein 1-like isoform X3
coiled-coil and C2 domain-containing protein 1-like isoform X2
coiled-coil and C2 domain-containing protein 1-like isoform X4
transcription factor Maf, transcript variant X1
transcription factor Maf, transcript variant X2
sodium channel protein Nach-like, transcript variant X5
sodium channel protein Nach-like, transcript variant X1
sodium channel protein Nach-like, transcript variant X4
sodium channel protein Nach-like, transcript variant X6
sodium channel protein Nach-like isoform X1
sodium channel protein Nach-like isoform X4
sodium channel protein Nach-like isoform X5
sodium channel protein Nach-like isoform X3
sodium channel protein Nach-like, transcript variant X3
sodium channel protein Nach-like, transcript variant X2
sodium channel protein Nach-like isoform X2
uncharacterized protein LOC114878450 isoform X2
putative leucine-rich repeat-containing protein DDB_G0290503
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC114878405
probable phosphatase phospho2, transcript variant X4
probable phosphatase phospho2, transcript variant X2
probable phosphatase phospho2, transcript variant X1
probable phosphatase phospho2 isoform X1
probable phosphatase phospho2, transcript variant X3
probable phosphatase phospho2 isoform X2
zinc finger MYND domain-containing protein 11, transcript variant X2
zinc finger MYND domain-containing protein 11, transcript variant X1
zinc finger MYND domain-containing protein 11, transcript variant X4
zinc finger MYND domain-containing protein 11, transcript variant X3
zinc finger MYND domain-containing protein 11 isoform X1
zinc finger MYND domain-containing protein 11 isoform X2
eukaryotic translation initiation factor 4 gamma 3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 6 codons; deleted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 6 codons; deleted 3 bases in 3 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: eukaryotic translation initiation factor 4 gamma 3-like
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00563
zinc finger CCCH domain-containing protein 10-like, transcript variant X1
zinc finger CCCH domain-containing protein 10-like, transcript variant X3
zinc finger CCCH domain-containing protein 10-like, transcript variant X2
G patch domain-containing protein 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
G patch domain-containing protein 11, transcript variant X1
zinc finger CCCH domain-containing protein 10-like isoform X1
zinc finger CCCH domain-containing protein 10-like isoform X2
dephospho-CoA kinase domain-containing protein
rho GTPase-activating protein 26-like, transcript variant X2
rho GTPase-activating protein 26-like, transcript variant X3
rho GTPase-activating protein 26-like, transcript variant X1
rho GTPase-activating protein 26-like, transcript variant X5
rho GTPase-activating protein 26-like isoform X2
rho GTPase-activating protein 26-like isoform X1
rho GTPase-activating protein 26-like isoform X4
rho GTPase-activating protein 26-like, transcript variant X4
rho GTPase-activating protein Graf-like isoform X3
transcription factor SPT20 homolog, transcript variant X1
transcription factor SPT20 homolog, transcript variant X4
transcription factor SPT20 homolog, transcript variant X2
transcription factor SPT20 homolog, transcript variant X3
transcription factor SPT20 homolog isoform X1
transcription factor SPT20 homolog isoform X2
patatin-like phospholipase domain-containing protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: patatin-like phospholipase domain-containing protein 2
ankyrin repeat and LEM domain-containing protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 7 codons; deleted 4 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 73% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 7 codons; deleted 4 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ankyrin repeat and LEM domain-containing protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 5 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 5 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: clathrin light chain
nuclear fragile X mental retardation-interacting protein 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: nuclear fragile X mental retardation-interacting protein 1-like
RNA cytidine acetyltransferase, transcript variant X1
RNA cytidine acetyltransferase, transcript variant X2
adenosine kinase-like, transcript variant X1
adenosine kinase-like, transcript variant X2
circadian locomoter output cycles protein kaput-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: putative protein FAM10A4
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X3
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X6
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X5
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X8
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X7
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X9
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X10
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X11
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X12
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X4
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X3
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X1
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X1
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X13
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X14
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X4
eukaryotic translation initiation factor 4 gamma 2, transcript variant X1
eukaryotic translation initiation factor 4 gamma 2, transcript variant X3
eukaryotic translation initiation factor 4 gamma 2, transcript variant X2
eukaryotic translation initiation factor 4 gamma 2
cGMP-dependent 3',5'-cyclic phosphodiesterase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
cGMP-dependent 3',5'-cyclic phosphodiesterase-like isoform X1
cGMP-dependent 3',5'-cyclic phosphodiesterase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cGMP-dependent 3',5'-cyclic phosphodiesterase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cGMP-dependent 3',5'-cyclic phosphodiesterase-like isoform X2
inner centromere protein, transcript variant X2
inner centromere protein, transcript variant X1
inner centromere protein, transcript variant X4
inner centromere protein, transcript variant X3
WD repeat-containing protein on Y chromosome
tetratricopeptide repeat protein 8, transcript variant X3
tetratricopeptide repeat protein 8, transcript variant X4
tetratricopeptide repeat protein 8, transcript variant X1
tetratricopeptide repeat protein 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tetratricopeptide repeat protein 8 isoform X1
tetratricopeptide repeat protein 8 isoform X2
tetratricopeptide repeat protein 8 isoform X3
coiled-coil domain-containing protein 134-like, transcript variant X1
coiled-coil domain-containing protein 134-like, transcript variant X2
coiled-coil domain-containing protein 134-like
NADH dehydrogenase [ubiquinone] 1 subunit C2
cilia- and flagella-associated protein 70-like
TOG array regulator of axonemal microtubules protein 1, transcript variant X2
TOG array regulator of axonemal microtubules protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
TOG array regulator of axonemal microtubules protein 1 isoform X2
uncharacterized protein LOC114879568 isoform X1
mitochondrial import receptor subunit TOM70
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase
beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase, transcript variant X1
beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase, transcript variant X2
beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase
E3 ubiquitin-protein ligase RNF14-like, transcript variant X2
E3 ubiquitin-protein ligase RNF14-like, transcript variant X1
coiled-coil and C2 domain-containing protein 2A-like, transcript variant X3
coiled-coil and C2 domain-containing protein 2A-like, transcript variant X4
coiled-coil and C2 domain-containing protein 2A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
coiled-coil and C2 domain-containing protein 2A-like, transcript variant X2
coiled-coil and C2 domain-containing protein 2A-like isoform X2
coiled-coil and C2 domain-containing protein 2A-like isoform X1
elongation of very long chain fatty acids protein 4-like, transcript variant X4
elongation of very long chain fatty acids protein 4-like, transcript variant X5
elongation of very long chain fatty acids protein 4-like, transcript variant X2
elongation of very long chain fatty acids protein 4-like, transcript variant X3
elongation of very long chain fatty acids protein 4-like, transcript variant X1
elongation of very long chain fatty acids protein 4-like isoform X1
elongation of very long chain fatty acids protein 4-like isoform X2
glycine receptor subunit alpha-2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glycine receptor subunit alpha-2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glycine receptor subunit alpha-2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glycine receptor subunit alpha-2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glycine receptor subunit alpha-2 isoform X2
glycine receptor subunit alpha-2, transcript variant X6
glycine receptor subunit alpha-2, transcript variant X1
glycine receptor subunit alpha-2 isoform X3
glycine receptor subunit alpha-2 isoform X1
periodic tryptophan protein 2 homolog, transcript variant X2
periodic tryptophan protein 2 homolog, transcript variant X1
periodic tryptophan protein 2 homolog isoform X2
periodic tryptophan protein 2 homolog isoform X1
V-type proton ATPase 16 kDa proteolipid subunit
centrosomal protein of 135 kDa, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
centrosomal protein of 135 kDa, transcript variant X1
centrosomal protein of 135 kDa, transcript variant X2
centrosomal protein of 135 kDa, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
centrosomal protein of 135 kDa isoform X1
centrosomal protein of 135 kDa isoform X3
centrosomal protein of 135 kDa isoform X2
centrosomal protein of 135 kDa isoform X4
uncharacterized LOC114879559, transcript variant X1
uncharacterized LOC114879559, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC114879559, transcript variant X3
uncharacterized protein LOC114879559 isoform X1
uncharacterized protein LOC114879559 isoform X2
AT-rich interactive domain-containing protein 2, transcript variant X2
AT-rich interactive domain-containing protein 2, transcript variant X1
AT-rich interactive domain-containing protein 2 isoform X2
AT-rich interactive domain-containing protein 2 isoform X1
serine--tRNA synthetase-like protein Slimp
thyrotropin-releasing hormone receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
thyrotropin-releasing hormone receptor-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
thyrotropin-releasing hormone receptor-like, transcript variant X3
thyrotropin-releasing hormone receptor-like, transcript variant X2
thyrotropin-releasing hormone receptor-like, transcript variant X5
thyrotropin-releasing hormone receptor-like
MOB kinase activator-like 2, transcript variant X4
MOB kinase activator-like 2, transcript variant X11
MOB kinase activator-like 2, transcript variant X1
MOB kinase activator-like 2, transcript variant X2
MOB kinase activator-like 2, transcript variant X3
MOB kinase activator-like 2, transcript variant X7
MOB kinase activator-like 2, transcript variant X9
MOB kinase activator-like 2, transcript variant X10
MOB kinase activator-like 2, transcript variant X5
MOB kinase activator-like 2, transcript variant X8
MOB kinase activator-like 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Wilms tumor protein homolog, transcript variant X3
Wilms tumor protein homolog, transcript variant X2
Wilms tumor protein homolog, transcript variant X1
cilia- and flagella-associated protein 43
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
uncharacterized LOC114882724, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC114882724 isoform X1
uncharacterized LOC114882724, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC114882724 isoform X2
probable E3 ubiquitin-protein ligase bre1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
G-patch domain and KOW motifs-containing protein
DNA N6-methyl adenine demethylase-like, transcript variant X2
DNA N6-methyl adenine demethylase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC114882722 isoform X2
DNA N6-methyl adenine demethylase-like isoform X1
adrenodoxin-like protein 2, mitochondrial
survival of motor neuron protein, transcript variant X4
survival of motor neuron protein, transcript variant X3
survival of motor neuron protein, transcript variant X1
survival of motor neuron protein, transcript variant X2
survival of motor neuron protein isoform X1
survival motor neuron protein isoform X2
survival motor neuron protein isoform X3
katanin p60 ATPase-containing subunit A-like 2, transcript variant X2
katanin p60 ATPase-containing subunit A-like 2, transcript variant X1
katanin p60 ATPase-containing subunit A-like 2 isoform X2
katanin p60 ATPase-containing subunit A-like 2 isoform X1
uncharacterized LOC114882639, transcript variant X1
uncharacterized protein LOC114882639 isoform X1
uncharacterized LOC114882639, transcript variant X2
uncharacterized protein LOC114882639 isoform X2
gonadal protein gdl, transcript variant X4
gonadal protein gdl, transcript variant X1
gonadal protein gdl, transcript variant X3
gonadal protein gdl, transcript variant X2
gamma-tubulin complex component 2-like, transcript variant X1
gamma-tubulin complex component 2-like, transcript variant X2
gamma-tubulin complex component 2-like isoform X1
gamma-tubulin complex component 2-like isoform X2
transient receptor potential cation channel protein painless
N-acetylglucosamine-6-phosphate deacetylase
polypeptide N-acetylgalactosaminyltransferase 35A-like, transcript variant X1
polypeptide N-acetylgalactosaminyltransferase 35A-like, transcript variant X3
polypeptide N-acetylgalactosaminyltransferase 35A-like, transcript variant X5
polypeptide N-acetylgalactosaminyltransferase 35A-like, transcript variant X4
polypeptide N-acetylgalactosaminyltransferase 35A-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 35A-like, transcript variant X2
polypeptide N-acetylgalactosaminyltransferase 35A-like isoform X1
polypeptide N-acetylgalactosaminyltransferase 35A-like isoform X2